Please assess the completion status of the following clinical trial:

Trial Title: Erector Spinae Plane Block For Lumbar Disc Hernia Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-II~* Age 18-65 years~* Undergoing elective lomber disc hernia~Exclusion Criteria:~* obesity~* ASA III - IV~* infection of the skin at the site of needle puncture area~* patients with known allergies to any of the study drugs~* coagulopathy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Erector Spinae Plane Block (Type: ACTIVE_COMPARATOR): Erector Spinae Plane Block Group~Block Drug: 0,25% bupivacaine hydrochloride (20ml) will be used for blocks
- Control Group (Type: SHAM_COMPARATOR): Sham block will be done with serum physiologic.

Based on this trial design, predict the completion outcome and termination type (if applicable).